Endocrine-Disrupting Chemicals: Science and Policy

被引:2
|
作者
Hilz, Emily N. [1 ]
Gore, Andrea C. [1 ,2 ]
机构
[1] Univ Texas, Austin, TX USA
[2] Univ Texas, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA
基金
美国国家卫生研究院;
关键词
endocrine-disrupting chemical (EDC); reproduction; epigenetics; public health; regulatory policy; Environmental Protection Agency; TESTICULAR DYSGENESIS SYNDROME; IN-UTERO EXPOSURE; BISPHENOL-A; POLYFLUOROALKYL SUBSTANCES; POLYCHLORINATED-BIPHENYLS; TISSUE-SPECIFICITY; GREEN CHEMISTRY; RISK; IDENTIFICATION; EXPRESSION;
D O I
10.1177/23727322231196794
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Endocrine-disrupting chemicals (EDCs) are chemicals that disrupt the normal functioning of endocrine system hormones, leading to a range of adverse health effects in humans and wildlife. Exposure to EDCs is ubiquitous and occurs through contaminated food and water, air, consumer products, and transfer from parents to offspring. Effective regulation has been challenging due to a limited understanding of EDCs' complex and nonlinear dose-response relationships, as well as difficulty in attributing specific health effects to individual EDC exposures in real-world scenarios. Current EDC policies face limitations in terms of the diversity and complexity of EDCs, the lack of comprehensive testing requirements, and the need for more robust regulatory frameworks that consider cumulative and mixture effects of EDCs. Understanding these aspects is crucial for developing effective and evidence-based EDC policies that can safeguard public health and the environment.
引用
收藏
页码:142 / 150
页数:9
相关论文
共 50 条
  • [21] Endocrine-Disrupting Chemicals and Child Health
    Ghassabian, Akhgar
    Vandenberg, Laura
    Kannan, Kurunthachalam
    Trasande, Leonardo
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 573 - 594
  • [22] Endocrine-disrupting chemicals and child health
    Kiess, Wieland
    Haeussler, Gabriele
    Vogel, Mandy
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (05)
  • [23] Endocrine-Disrupting Chemicals: Introduction to the Theme
    Lisco, Giuseppe
    Giagulli, Vito Angelo
    Iovino, Michele
    Guastamacchia, Edoardo
    De Pergola, Giovanni
    Triggiani, Vincenzo
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (07) : 677 - 685
  • [24] Endocrine-Disrupting Chemicals in Cosmetics Reply
    Rubin, Courtney Blair
    Brod, Bruce A.
    [J]. JAMA DERMATOLOGY, 2020, 156 (05) : 604 - 604
  • [25] Endocrine-disrupting chemicals and skin manifestations
    Qiang Ju
    Christos C. Zouboulis
    [J]. Reviews in Endocrine and Metabolic Disorders, 2016, 17 : 449 - 457
  • [26] Endocrine-disrupting chemicals and skin manifestations
    Ju, Qiang
    Zouboulis, Christos C.
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03): : 449 - 457
  • [27] The challenge posed by endocrine-disrupting chemicals
    Ashby, J
    Houthoff, E
    Kennedy, SJ
    Stevens, J
    Bars, R
    Jekat, FW
    Campbell, P
    VanMiller, J
    Carpanini, FM
    Randall, GLP
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (02) : 164 - 169
  • [28] Endocrine-Disrupting Chemicals and Disease Endpoints
    Ahn, Changhwan
    Jeung, Eui-Bae
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [29] Endocrine-disrupting chemicals and uterine fibroids
    Katz, Tiffany A.
    Yang, Qiwei
    Trevino, Lindsey S.
    Walker, Cheryl Lyn
    Al-Hendy, Ayman
    [J]. FERTILITY AND STERILITY, 2016, 106 (04) : 967 - 977
  • [30] The burden of endocrine-disrupting chemicals in the USA
    Andreas Kortenkamp
    [J]. Nature Reviews Endocrinology, 2017, 13 : 6 - 7